DK2882421T3 - Liposom-sammensætning til brug i peritonealdialyse - Google Patents

Liposom-sammensætning til brug i peritonealdialyse Download PDF

Info

Publication number
DK2882421T3
DK2882421T3 DK13745798.2T DK13745798T DK2882421T3 DK 2882421 T3 DK2882421 T3 DK 2882421T3 DK 13745798 T DK13745798 T DK 13745798T DK 2882421 T3 DK2882421 T3 DK 2882421T3
Authority
DK
Denmark
Prior art keywords
peritoneal dialysis
liposome composition
dialysis use
liposome
composition
Prior art date
Application number
DK13745798.2T
Other languages
English (en)
Inventor
Jean-Christophe Leroux
Vincent Forster
Original Assignee
Eth Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eth Zuerich filed Critical Eth Zuerich
Application granted granted Critical
Publication of DK2882421T3 publication Critical patent/DK2882421T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK13745798.2T 2012-08-09 2013-08-06 Liposom-sammensætning til brug i peritonealdialyse DK2882421T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12005796.3A EP2695606A1 (en) 2012-08-09 2012-08-09 Liposome composition for peritoneal dialysis
PCT/EP2013/002352 WO2014023421A1 (en) 2012-08-09 2013-08-06 Liposome composition for use in peritoneal dialysis

Publications (1)

Publication Number Publication Date
DK2882421T3 true DK2882421T3 (da) 2022-07-04

Family

ID=47022433

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13745798.2T DK2882421T3 (da) 2012-08-09 2013-08-06 Liposom-sammensætning til brug i peritonealdialyse

Country Status (15)

Country Link
US (3) US10596114B2 (da)
EP (3) EP2695606A1 (da)
JP (1) JP5956075B2 (da)
KR (2) KR101966308B1 (da)
CN (2) CN110269841A (da)
AU (1) AU2013301901B9 (da)
BR (2) BR122019024753B1 (da)
CA (1) CA2894784C (da)
DK (1) DK2882421T3 (da)
ES (1) ES2922278T3 (da)
HK (1) HK1209059A1 (da)
MX (1) MX362882B (da)
PT (1) PT2882421T (da)
RU (1) RU2609860C2 (da)
WO (1) WO2014023421A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2695606A1 (en) * 2012-08-09 2014-02-12 ETH Zürich Liposome composition for peritoneal dialysis
WO2016048242A1 (en) * 2014-09-24 2016-03-31 Nanyang Technological University Sustained timolol maleate delivery from liposomes for glaucoma therapy and ocular hypertension
US10710044B2 (en) 2015-04-02 2020-07-14 Nanyang Technological University Tubular and vesicular architectures formed from polymer-lipid blends and method for forming the same
JP6715265B2 (ja) * 2015-05-04 2020-07-01 フェルザンティス アーゲーＶｅｒｓａｎｔｉｓ Ａｇ 膜内外ｐＨ勾配ベシクルを調製する方法
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
US20190127736A1 (en) * 2016-04-29 2019-05-02 Aptamir Therapeutics, Inc. Inhibition of mir-22 mirna by apt-110
CN106220562B (zh) * 2016-07-29 2019-10-01 上海璃道医药科技有限公司 两种喹啉环类药物的新用途
EP3500311B1 (en) 2016-08-16 2020-05-27 ETH Zurich Transmembrane ph-gradient polymersomes and their use in the scavenging of ammonia and its methylated analogs
EP3668927B1 (en) * 2017-09-12 2024-03-20 ETH Zurich Transmembrane ph-gradient polymersomes for the quantification of ammonia in body fluids
KR20190085734A (ko) 2018-01-11 2019-07-19 이광영 말뚝의 결합장치
US20210015844A1 (en) * 2018-03-14 2021-01-21 Beacon Medcare (Hk) Limited Composition for purification of biofluids
CN111939126A (zh) * 2019-05-15 2020-11-17 上海交通大学医学院附属第九人民医院 一种阳离子脂质体、包含所述脂质体的分散液及它们的制备方法和用途
CN109966277B (zh) * 2019-05-23 2021-04-30 济宁医学院附属医院 一种治疗难治性癫痫的药物组合物及其应用
CN112294763A (zh) * 2019-07-30 2021-02-02 上海交通大学医学院附属第九人民医院 一种腹膜透析用脂质体分散液及其制备方法和用途
KR20210128169A (ko) 2020-04-16 2021-10-26 이광영 파일 결합 장치
US20240000754A1 (en) 2020-11-17 2024-01-04 Genfit Methods of treatment of liver failure
CN112933045B (zh) * 2021-04-09 2022-04-12 贵州医科大学 共载双氢青蒿素/磷酸氯喹双敏感纳米制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE446063B (sv) 1978-02-01 1986-08-11 Exxon Research Engineering Co Vetskemembrankapsel som er motstandskrafitg mot koalescens och forfarande for framstellning av vetskemembrankapslar
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US20040208922A1 (en) * 1995-06-07 2004-10-21 The Regents Of The University Of California Method for loading lipid like vesicles with drugs or other chemicals
US5972905A (en) * 1995-06-14 1999-10-26 Institute Of Immunology Co., Ltd. Use of oligosaccharides for the treatment of pruritus cutaneus associated with renal failure
EP0863748A4 (en) * 1995-10-11 1999-11-03 Kevin Jon William LIPOSOMAL COMPOSITIONS AND METHODS OF USE
CN1160585A (zh) * 1995-12-22 1997-10-01 贝尔科公开有限公司 除去脂溶性靶分子的方法，纯化血液的透析装置及洗涤溶液
DE10117043A1 (de) * 2001-04-05 2002-11-07 Gerhard Puetz Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
US20030129224A1 (en) * 2001-11-13 2003-07-10 Paul Tardi Lipid carrier compositions and methods for improved drug retention
US20090306625A1 (en) * 2007-03-09 2009-12-10 Angiodynamics, Inc. Treatment systems and methods for renal-related diseases
JP5450612B2 (ja) * 2008-06-18 2014-03-26 ライフボンド リミテッド 改良された架橋組成物
EP2695606A1 (en) * 2012-08-09 2014-02-12 ETH Zürich Liposome composition for peritoneal dialysis

Also Published As

Publication number Publication date
PT2882421T (pt) 2022-07-14
BR112015002584A8 (pt) 2019-07-30
CA2894784A1 (en) 2014-02-13
EP4062905A1 (en) 2022-09-28
BR112015002584B1 (pt) 2023-03-07
AU2013301901B9 (en) 2018-06-14
JP5956075B2 (ja) 2016-07-20
HK1209059A1 (en) 2016-03-24
US10596114B2 (en) 2020-03-24
MX2015000740A (es) 2015-04-14
US20190105270A1 (en) 2019-04-11
US11896712B2 (en) 2024-02-13
EP2882421B1 (en) 2022-06-01
KR20150034200A (ko) 2015-04-02
WO2014023421A9 (en) 2015-01-08
MX362882B (es) 2019-02-22
KR20170097240A (ko) 2017-08-25
EP2695606A1 (en) 2014-02-12
WO2014023421A1 (en) 2014-02-13
KR101993775B1 (ko) 2019-06-27
CA2894784C (en) 2018-02-20
EP2882421A1 (en) 2015-06-17
CN104519873A (zh) 2015-04-15
AU2013301901B2 (en) 2016-03-10
RU2014153193A (ru) 2016-07-20
CN110269841A (zh) 2019-09-24
BR112015002584A2 (pt) 2017-07-04
AU2013301901A1 (en) 2015-01-22
KR101966308B1 (ko) 2019-04-05
BR122019024753B1 (pt) 2023-03-07
US20210128470A1 (en) 2021-05-06
RU2609860C2 (ru) 2017-02-06
ES2922278T3 (es) 2022-09-12
JP2015524452A (ja) 2015-08-24
US20150216802A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
DK2882421T3 (da) Liposom-sammensætning til brug i peritonealdialyse
DK2872485T3 (da) Asymmetrisk hjælpegruppe
BR112013030076A2 (pt) membranas
BR112013032887A2 (pt) cateter
BR112014012778A2 (pt) embalagem de cateter
EP2841078A4 (en) POLYMER-BASED DIALYSIS
BR302013000908S1 (pt) Configuração aplicada em colchão
BR112014007980A2 (pt) máquina de diálise peritonial
FR2997471B1 (fr) Tuyauterie composite
EP2926835A4 (en) FLUID FOR PERITONEAL DIALYSIS
DE112013001932A5 (de) Mikro-Pilotventil
BR112014009956A2 (pt) sachê de embalagem
FR2998025B1 (fr) Vanne
BR112014032823A2 (pt) aperfeiçoamentos em rolamentos fluidos
BR112014032413A2 (pt) tanque
BR302012006318S1 (pt) Configuração aplicada em vaporizador de produtos fluidos
EP2926836A4 (en) peritoneal
BR302012006320S1 (pt) Configuração aplicada em vaporizador de produtos fluidos
BR302012003846S1 (pt) Configuração aplicada em almofada
BR112013012181A2 (pt) membranas
DE112013004054A5 (de) Fluidfilter
DK2526992T3 (da) Kateterventil
FR2988587B1 (fr) Composition auto-emulsionnante
FR2997474B1 (fr) Raccord modulaire
PL2609915T3 (pl) Płyn dializacyjny i substytucyjny